3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Classical hematology
1
Conditions
Prostatic Neoplasms
83
Breast Neoplasms
52
Salivary Gland Neoplasms
3
Prostate Adenocarcinoma
3
Neoplasms
3
Triple Negative Breast Neoplasms
2
Recurrence
2
Osteoporosis
2
Neoplasm Metastasis
2
Leiomyoma
2
Breast Neoplasms, Male
2
Advanced Breast Cancer
2
Stage I Prostate Adenocarcinoma AJCC v7
1
Sexual Dysfunctions, Psychological
1
Sexual Dysfunction, Physiological
1
Sarcopenia
1
Radiation Injuries
1
Primary Ovarian Insufficiency
1
Primary Dysautonomias
1
Patients With T1-4 Advanced Prostate Cancer
1
Patient Compliance
1
PSA Level Greater Than Two
1
Ovarian Neoplasms
1
Myofibroma
1
Lymphatic Metastasis
1
Kidney Diseases
1
Hypertension
1
Hyperlipidemias
1
Hot Flashes
1
Hormone-sensitive Metastatic Breast Cancer
1
Interventions
Epoetin Alfa
10
Darbepoetin alfa
8
ferric carboxymaltose
7
fludarabine
4
Cyclophosphamide
4
Busulfan
4
Blood Transfusion
4
fludarabine phosphate
3
Filgrastim
3
Erythrocyte Transfusion
3
Cyclosporine
3
Biopsy
3
Antilymphocyte Serum
3
thymoglobulin
2
ruxolitinib
2
iron isomaltoside 1000
2
ferrous sulfate
2
ferrous fumarate
2
ferric gluconate
2
Vitamin B 12
2
Thiotepa
2
Therapeutics
2
Taxes
2
Surveys and Questionnaires
2
Peripheral Blood Stem Cell Transplantation
2
Methotrexate
2
Lenalidomide
2
Folic Acid
2
Ferric Oxide, Saccharated
2
Carboplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Anemia
×
Goserelin
×
Clear all
NCT00303784
2020-11-27
PATCH
University College, London
Phase 3
Unknown
2,200 enrolled